A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies

E. Turro, D. Greene, A. Wijgaerts, C. Thys, C. Lentaigne, T.K. Bariana, S.K. Westbury, A.M. Kelly, D. Selleslag, J.C. Stephens, S. Papadia, I. Simeoni, C.J. Penkett, S. Ashford, A. Attwood, S. Austin, T. Bakchoul, P. Collins, S.V.V. Deevi, R. FavierM. Kostadima, M.P. Lambert, M. Mathias, C.M. Millar, K. Peerlinck, D.J. Perry, S. Schulman, D. Whitehorn, C. Wittevrongel, M. De Maeyer, A. Rendon, K. Gomez, Wendy N. Erber, A.D. Mumford, P. Nurden, K. Stirrups, J.R. Bradley, F.L. Raymond, M.A. Laffan, C. Van Geet, S. Richardson, K. Freson, H. Ouwehand

Research output: Contribution to journalArticlepeer-review

94 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science